PRPO
Precipio, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$26.62
+1.92%Margins
Gross margin
43.7%
EBITDA margin
0.9%
EBIT margin
-5.6%
Net margin
-4.4%
FCF margin
2.9%
-8.2%
Return on equity
-5.7%
Return on assets
-8.5%
Return on invested capital
1.30x
Asset turnover
$1.1M
Cash from operations
$1.72
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026